{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:53:37Z","timestamp":1774126417001,"version":"3.50.1"},"reference-count":47,"publisher":"Europa Digital & Publishing","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.4244\/eij-d-17-00463","type":"journal-article","created":{"date-parts":[[2017,8,27]],"date-time":"2017-08-27T07:45:49Z","timestamp":1503819949000},"page":"751-759","source":"Crossref","is-referenced-by-count":6,"title":["State of the art: optimal medical therapy \u2013 competing with or complementary to revascularisation in patients with coronary artery disease?"],"prefix":"10.4244","volume":"13","author":[{"given":"Javaid","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2017826231247-0","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.jacc.2003.08.025","article-title":"The Simon Dack lecture. Cardiology: the past, the present, and the future.","volume":"42","author":"Braunwald E.","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"key-2017826231247-1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrd1112","article-title":"Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.","volume":"2","author":"Tobert JA.","year":"2003","journal-title":"Nat Rev Drug Discov."},{"key":"key-2017826231247-2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(98)03212-7","article-title":"Evolution of the management of acute myocardial infarction: a 20th century saga.","volume":"352","author":"Braunwald E.","year":"1998","journal-title":"Lancet."},{"key":"key-2017826231247-3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"_-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.","volume":"308","author":"Bangalore S.","year":"2012","journal-title":"JAMA."},{"key":"key-2017826231247-4","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","article-title":"Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.","volume":"131","author":"Iqbal J.","year":"2015","journal-title":"Circulation."},{"key":"key-2017826231247-5","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1161\/CIRCULATIONAHA.114.014209","article-title":"Efficacy of Long-Term _-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.","volume":"131","author":"Zhang H.","year":"2015","journal-title":"Circulation."},{"key":"key-2017826231247-6","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).","volume":"35","author":"Windecker S.","year":"2014","journal-title":"Eur Heart J."},{"key":"key-2017826231247-7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.","volume":"122","author":"Hueb W.","year":"2010","journal-title":"Circulation."},{"key":"key-2017826231247-8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.","volume":"344","author":"Yusuf S.","year":"1994","journal-title":"Lancet."},{"key":"key-2017826231247-9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease.","volume":"356","author":"Boden WE.","year":"2007","journal-title":"N Engl J Med."},{"key":"key-2017826231247-10","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.","volume":"117","author":"Shaw LJ.","year":"2008","journal-title":"Circulation."},{"key":"key-2017826231247-11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ahj.2012.05.018","article-title":"Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.","volume":"164","author":"Shaw LJ.","year":"2012","journal-title":"Am Heart J."},{"key":"key-2017826231247-12","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease.","volume":"360","author":"Frye RL.","year":"2009","journal-title":"N Engl J Med."},{"key":"key-2017826231247-13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.","volume":"367","author":"De Bruyne B.","year":"2012","journal-title":"N Engl J Med."},{"key":"key-2017826231247-14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/archinternmed.2011.1484","article-title":"Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.","volume":"172","author":"Stergiopoulos K.","year":"2012","journal-title":"Arch Intern Med."},{"key":"key-2017826231247-15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jcin.2013.07.003","article-title":"Percutaneous coronary intervention versus medical therapy in stable coronary artery disease: the unresolved conundrum.","volume":"6","author":"Epstein SE.","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"key-2017826231247-16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","author":"Antithrombotic Trialists' Collaboration.","year":"2002","journal-title":"BMJ."},{"key":"key-2017826231247-17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/FJC.0000000000000052","article-title":"Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials.","volume":"63","author":"Verdoia M.","year":"2014","journal-title":"J Cardiovasc Pharmacol."},{"key":"key-2017826231247-18","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott SD.","year":"2007","journal-title":"N Engl J Med."},{"key":"key-2017826231247-19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.","volume":"367","author":"Roe MT.","year":"2012","journal-title":"N Engl J Med."},{"key":"key-2017826231247-20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin L.","year":"2009","journal-title":"N Engl J Med."},{"key":"key-2017826231247-21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.","volume":"355","author":"Flather MD.","year":"2000","journal-title":"Lancet."},{"key":"key-2017826231247-22","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.115.021183","article-title":"Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.","volume":"134","author":"Kurlansky P.","year":"2016","journal-title":"Circulation."},{"key":"key-2017826231247-23","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.","volume":"120","author":"Chaitman BR.","year":"2009","journal-title":"Circulation."},{"key":"key-2017826231247-24","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1161\/01.CIR.0000146337.05073.22","article-title":"Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound.","volume":"110","author":"Rioufol G.","year":"2004","journal-title":"Circulation."},{"key":"key-2017826231247-25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJR.0b013e3283313592","article-title":"Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.","volume":"17","author":"Piepoli MF.","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"key-2017826231247-26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2004.09.065","article-title":"Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials.","volume":"45","author":"Okrainec K.","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"key-2017826231247-27","doi-asserted-by":"publisher","first-page":"I207","DOI":"10.1161\/CIRCULATIONAHA.106.681247","article-title":"Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database.","volume":"116","author":"Hiratzka LF.","year":"2007","journal-title":"Circulation."},{"key":"key-2017826231247-28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.","volume":"113","author":"Newby LK.","year":"2006","journal-title":"Circulation."},{"key":"key-2017826231247-29","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1001\/jama.2011.601","article-title":"Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.","volume":"305","author":"Borden WB.","year":"2011","journal-title":"JAMA."},{"key":"key-2017826231247-30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bmj.38695.605440.AE","article-title":"Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study.","volume":"332","author":"Daly CA.","year":"2006","journal-title":"BMJ."},{"key":"key-2017826231247-31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.116.024531","article-title":"Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.","volume":"134","author":"Resor CD.","year":"2016","journal-title":"Circulation."},{"key":"key-2017826231247-32","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMe058053","article-title":"Methods of coronary revascularization--things may not be as they seem.","volume":"352","author":"Gersh BJ.","year":"2005","journal-title":"N Engl J Med."},{"key":"key-2017826231247-33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.21037\/atm.2017.02.15","article-title":"Optimal medical therapy is vital for patients with coronary artery disease and acute coronary syndromes regardless of revascularization strategy.","volume":"5","author":"Iqbal J.","year":"2017","journal-title":"Ann Transl Med."},{"key":"key-2017826231247-34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2013.277064","article-title":"Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.","volume":"310","author":"Thom S.","year":"2013","journal-title":"JAMA."},{"key":"key-2017826231247-35","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1001\/jama.2013.4638","article-title":"Medication nonadherence: a diagnosable and treatable medical condition.","volume":"309","author":"Marcum ZA.","year":"2013","journal-title":"JAMA."},{"key":"key-2017826231247-36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.110.981068","article-title":"Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.","volume":"123","author":"Williams JB.","year":"2011","journal-title":"Circulation."},{"key":"key-2017826231247-37","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jacc.2013.01.044","article-title":"Risk factor control for coronary artery disease secondary prevention in large randomized trials.","volume":"61","author":"Farkouh ME.","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"key-2017826231247-38","doi-asserted-by":"publisher","first-page":"e36284","DOI":"10.1371\/journal.pone.0036284","article-title":"Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.","volume":"7","author":"Steg PG.","year":"2012","journal-title":"PLoS One."},{"key":"key-2017826231247-39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jacc.2015.06.019","article-title":"Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.","volume":"66","author":"Bittner V.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-2017826231247-40","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2015.01.014","article-title":"Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.","volume":"65","author":"Zhang YJ.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-2017826231247-41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0735-1097(92)90092-2","article-title":"Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators.","volume":"20","author":"Cavender JB.","year":"1992","journal-title":"J Am Coll Cardiol."},{"key":"key-2017826231247-42","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/CIRCULATIONAHA.107.701466","article-title":"Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery.","volume":"116","author":"Suaya JA.","year":"2007","journal-title":"Circulation."},{"key":"key-2017826231247-43","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/CIRCULATIONAHA.104.503995","article-title":"Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review.","volume":"112","author":"Iestra JA.","year":"2005","journal-title":"Circulation."},{"key":"key-2017826231247-44","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1532\/HSF98.20081004","article-title":"Changing lifestyle habits as secondary prophylaxis after coronary artery bypass grafting.","volume":"11","author":"Vachenauer R.","year":"2008","journal-title":"Heart Surg Forum."},{"key":"key-2017826231247-45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jacbts.2016.03.012","article-title":"Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012.","volume":"1","author":"Hwang TJ.","year":"2016","journal-title":"JACC: Basic to Translational Science."},{"key":"key-2017826231247-46","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.","volume":"376","author":"Sabatine MS.","year":"2017","journal-title":"N Engl J Med."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,8,27]],"date-time":"2017-08-27T07:46:23Z","timestamp":1503819983000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/120th_issue\/110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["EIJ-D-17-00463"],"URL":"https:\/\/doi.org\/10.4244\/eij-d-17-00463","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}